Dhananjay B. Patankar
Keine laufenden Positionen mehr
Profil
Dhananjay B.
Patankar worked as the Head of Biopharmaceutical Development at Syngene International Ltd.
and as the Chief Operations & Technology Officer at Intas Biopharmaceuticals Ltd.
He holds a doctorate degree from the University of Utah and a graduate degree from the Indian Institute of Technology Bombay.
Ehemalige bekannte Positionen von Dhananjay B. Patankar
| Unternehmen | Position | Ende |
|---|---|---|
| SYNGENE INTERNATIONAL LIMITED | Corporate Officer/Principal | 01.06.2022 |
Intas Biopharmaceuticals Ltd.
 Intas Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Intas Biopharmaceuticals Ltd. researches and develops pharmaceutical products. It manufactures Pegylated GCSF in India and markets under the brand name NEUPEG. The company was founded in 2000 and is headquartered in Ahmedabad, India. | Geschäftsführer | - |
Ausbildung von Dhananjay B. Patankar
| University of Utah | Doctorate Degree |
| Indian Institute of Technology Bombay | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYNGENE INTERNATIONAL LIMITED | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Intas Biopharmaceuticals Ltd.
Intas Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Intas Biopharmaceuticals Ltd. researches and develops pharmaceutical products. It manufactures Pegylated GCSF in India and markets under the brand name NEUPEG. The company was founded in 2000 and is headquartered in Ahmedabad, India. | Health Technology |
